查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927672

全球感染疾病诊断剂市场：按产品类型、技术、疾病类型、应用、最终用户、国家和地区分類的行业分析、市场规模、份额和2025-2032年预测

Diagnostic Reagents for Infectious Diseases Market, By Product Type, By Technology, By Disease Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 356 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，感染疾病诊断剂市场规模将达到 33.1531 亿美元，从 2025 年到 2032 年，复合年增长率将达到 9.23%。

感染疾病诊断剂是用于检测病原体的重要生化试剂，其作用在于准确识别细菌、病毒、真菌和寄生虫。感染疾病的日益普及以及医院和检查室对早期准确诊断需求的不断增长，正在推动市场成长。开发与快速、自动化和照护现场诊断平台相容的高灵敏度试剂具有重要意义，使其在疫情管理和分散式检查中发挥关键作用。分子诊断和免疫检测分析试剂的进步是值得关注的趋势，这些进步能够加快检测速度并提高特异性。然而，试剂稳定性有限、依赖低温运输以及对不同病原体的性能差异等挑战，限制了其在资源匮乏环境中的应用以及长期储备以应对突发事件。

感染疾病诊断剂市场动态

感染疾病传播日益加剧，对诊断测试的需求不断增加

包括呼吸道感染疾病、结核病、爱滋病和新发病毒感染疾病在内的感染疾病日益流行，显着推动了对感染疾病诊断剂，这些试剂对于准确快速地检测疾病至关重要。随着医疗系统日益重视早期诊断和有效的疾病管理，实验室和医院需要高品质的试剂，以确保在不同诊断平台上的敏感度、特异性和可重复性。诊断剂在分子诊断、免疫检测和快速诊断测试中发挥至关重要的作用，它们能够实现病原体鑑定、抗原-抗体反应和核酸扩增。向快速和照护现场诊断的转变进一步增加了对能够在紧凑型自动化系统中提供稳定性能的试剂的需求。此外，不断扩大的疾病监测计画和常规筛检措施也在加速试剂的消耗。例如，近年来，国家公共卫生措施显着增加了感染疾病诊断检测的数量。此外，诊断检测在预防保健、医院感染控制和感染疾病应变的广泛应用，也持续推动医疗机构对可靠、高效能诊断剂的需求。

感染疾病诊断剂市场：細項分析

全球感染疾病诊断剂市场按产品类型、技术、疾病类型、应用、最终用户和地区进行细分。

依产品类型，市场区隔可分为四大类：分子诊断剂、免疫检测试剂、临床化学试剂、血液学试剂。在感染疾病诊断剂市场中，分子诊断剂占据主导地位。这主要归功于其在检测病原体DNA或RNA方面的高灵敏度和特异性，使其成为快速且准确地诊断病毒和细菌性行为感染的关键。免疫检测试剂位居第二，因其可靠性、扩充性和从照护现场检测到检查室环境的广泛适用性，被广泛应用于基于抗原-抗体的检测。临床化学试剂紧随其后，支持生物标记监测和疾病进展追踪等辅助检测，是感染疾病初级诊断的补充。血液学试剂的市占率虽小但不可忽视，尤其是在医院检查室，它们用于血球分析和感染控制中的免疫反应监测。总体而言，市场优先考虑因素反映了临床效用、技术复杂性以及对快速、高效能诊断解决方案的需求。

根据技术类型，市场可分为四个细分领域：PCR/RT-PCR、ELISA、萤光和次世代定序(NGS)。在各种技术类型中，PCR/RT-PCR 在感染疾病诊断剂市场占据主导地位。这得归功于其广泛的应用、高灵敏度以及基于核酸检测的快速病原体检测能力，使其成为分子诊断的黄金标准。 ELISA 位居第二，以其稳健性、易操作性和对多种感染疾病抗原和抗体检测的适用性而闻名。萤光能够精确地可视化和检测病原体，尤其适用于专业检查室应用，但需要更高级的技术知识。次世代定序(NGS) 已成为一项极具潜力的病原体全面分析和疫情追踪技术，但其高成本和基础设施要求限制了其应用。总体而言，技术优先级反映了临床诊断中灵敏度、易用性和扩充性。

感染疾病诊断剂市场－区域分析

北美地区在感染疾病诊断剂市场主导，拥有最大的市场份额。这主要得益于其完善的医疗保健基础设施、大量的研发投入以及先进分子诊断和免疫检测试剂的广泛应用，这些因素共同推动了临床和检查室对试剂的需求。美国引领区域成长，这得益于政府的筛检计画和私部门的积极参与。欧洲位居第二，德国、法国和英国等国家重视疾病的早期检测和高品质试剂的使用，并透过公私伙伴关係扩大检测能力。亚太地区正崛起为成长最快的市场，这主要归功于医疗保健支出的成长、实验室基础设施的扩张以及感染疾病流行率的上升，尤其是在中国、印度和日本。这些因素推动了当地试剂的使用和生产。策略发展包括：生物梅里埃公司于2025年6月收购DayZero Diagnostics，以扩展其试剂产品组合；以及希森美康和凯杰公司于2025年10月在日本建立试剂供应和分销合作伙伴关係。

感染疾病诊断剂市场—国家分析

从国家层级来看，美国在感染疾病诊断剂市场占据主导地位，这得益于其先进的医疗基础设施、分子检测的广泛应用以及公共和私营部门在疾病早期检测方面的大量投资。德国、英国和法国等西欧国家紧随其后，这得益于不断扩大的检测网络以及试剂在临床诊断和公共卫生筛检计画中的高效利用。在亚太地区，由于医疗保健支出不断增长、感染疾病率上升以及为减少进口依赖、提高试剂可及性并降低成本而采取的试剂供应链本地化倡议，中国和印度的试剂市场正在迅速扩张。

策略性措施包括：生物梅里埃于 2025 年 6 月收购 Day Zero Diagnostics，扩大其感染疾病试剂产品组合和次世代定序(NGS) 能力；以及 Sysmex 于 2025 年 10 月与 QIAGEN 合作，开始在日本销售感染疾病试剂和诊断产品。

目录

第一章感染疾病诊断剂市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章：感染疾病诊断剂的主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章感染疾病诊断剂市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章感染疾病诊断剂市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章感染疾病诊断剂的市场状况

  • 感染疾病诊断剂市占率分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章 依产品类型分類的感染疾病诊断剂市场

  • 概述
    • 细分市场占有率分析：依产品类型
    • 分子诊断剂
    • 免疫检测试剂
    • 临床化学试剂
    • 血液学试剂

第八章 按技术分類的感染疾病诊断剂市场

  • 概述
    • 细分市场占有率分析：依技术划分
    • PCR和RT-PCR
    • ELISA
    • 萤光
    • 次世代定序

第九章 依疾病类型分類的感染疾病诊断剂市场

  • 概述
    • 细分市场占有率分析：依疾病类型划分
    • 病毒感染疾病
    • 细菌感染疾病
    • 霉菌感染疾病
    • 寄生虫感染疾病

第十章 依应用分類的感染疾病诊断剂市场

  • 概述
    • 细分市场占有率分析：按应用
    • 疾病诊断
    • 血液筛检
    • 流行病学调查

第十一章感染疾病诊断剂市场（依最终用户划分）

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 医院
    • 诊断检查室
    • 血库
    • 研究所

第十二章 各地区感染疾病诊断剂市场

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十三章 主要供应商分析：感染疾病诊断剂产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • Abbott Laboratories
    • Agilent Technologies
    • Beckman Coulter
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories
    • Danaher Corporation
    • DiaSorin
    • Fujirebio
    • Grifols
    • Hologic
    • Merck KGaA
    • Ortho Clinical Diagnostics
    • QIAGEN
    • QuidelOrtho
    • Randox Laboratories
    • Roche Diagnostics
    • Sekisui Diagnostics
    • Siemens Healthineers
    • Sysmex Corporation
    • Thermo Fisher Scientific
    • Others

第十四章 AnalystView 360度分析

简介目录
Product Code: ANV5958

The Diagnostic Reagents for Infectious Diseases Market size was valued at US$ 3,315.31 Million in 2024, expanding at a CAGR of 9.23% from 2025 to 2032.

Diagnostic reagents for infectious diseases are essential biochemical substances used to detect pathogens by enabling accurate identification of bacteria, viruses, fungi, and parasites. The growing prevalence of infectious diseases and rising demand for early and precise diagnosis across hospitals and laboratories are driving market growth. Opportunities exist in developing high-sensitivity reagents compatible with rapid, automated, and point-of-care diagnostic platforms, which are critical for outbreak management and decentralized testing. A prominent trend is the advancement of molecular and immunoassay-based reagents that offer faster turnaround times and improved specificity. However, challenges such as limited reagent stability, cold-chain dependency, and variability in performance across different pathogens restrict adoption in resource-limited settings and long-term stockpiling for emergency preparedness.

Diagnostic Reagents for Infectious Diseases Market- Market Dynamics

Increasing prevalence of infectious diseases and expanding diagnostic testing

The rising prevalence of infectious diseases such as respiratory infections, tuberculosis, HIV, and emerging viral outbreaks is significantly driving demand for diagnostic reagents for infectious diseases, which are critical for accurate and timely disease detection. As healthcare systems increasingly prioritize early diagnosis and effective disease management, laboratories and hospitals require high-quality reagents that ensure sensitivity, specificity, and reproducibility across diagnostic platforms. Diagnostic reagents play a vital role in molecular, immunoassay, and rapid diagnostic tests by enabling pathogen identification, antigen-antibody reactions, and nucleic acid amplification. The growing shift toward rapid and point-of-care diagnostics further increases demand for reagents that deliver consistent performance in compact and automated systems. Moreover, expanding disease surveillance programs and routine screening initiatives are accelerating reagent consumption. For instance, national public health initiatives have significantly increased diagnostic testing volumes for infectious diseases in recent years. Additionally, the growing use of diagnostic testing in preventive healthcare, hospital infection control, and outbreak preparedness continues to drive the need for reliable, high-performance diagnostic reagents across healthcare settings.

Diagnostic Reagents for Infectious Diseases Market- Segmentation Analysis:

The Global Diagnostic Reagents for Infectious Diseases Market is segmented on the basis of Product Type, Technology, Disease Type, Application, End-User, and Region.

The market is segmented into four categories based on product type: molecular diagnostic reagents, immunoassay reagents, clinical chemistry reagents, and hematology reagents. Among product types, Molecular Diagnostic Reagents hold the highest priority in the diagnostic reagents for infectious diseases market, driven by their high sensitivity and specificity for detecting pathogen DNA or RNA, making them essential for rapid and accurate diagnosis of viral and bacterial infections. Immunoassay Reagents rank second, widely used in antigen-antibody-based testing due to their reliability, scalability, and applicability across point-of-care and laboratory settings. Clinical Chemistry Reagents follow, supporting supportive testing such as monitoring biomarkers and disease progression, which complements primary infectious disease diagnostics. Hematology Reagents hold a smaller yet significant share, as they are used for blood cell analysis and immune response monitoring in infection management, particularly in hospital laboratories. Overall, market prioritization reflects clinical utility, technological complexity, and demand for rapid, high-performance diagnostic solutions.

The market is categorized into four segments based on technology: PCR & RT-PCR, ELISA, immunofluorescence, and next-generation sequencing (NGS). Among technology types, PCR & RT-PCR hold the highest priority in the diagnostic reagents for infectious diseases market due to their widespread adoption, high sensitivity, and ability to provide rapid nucleic acid-based detection of pathogens, making them the gold standard for molecular diagnostics. ELISA ranks second, valued for its robustness, ease of use, and applicability in detecting antigens and antibodies across a wide range of infectious diseases in both laboratory and point-of-care settings. Immunofluorescence follows, offering precise visualization and detection of pathogens, particularly in specialized laboratory applications, though it requires more technical expertise. Next-Generation Sequencing (NGS) ranks next, emerging as a high-potential technology for comprehensive pathogen profiling and outbreak tracking, yet its adoption is limited by higher costs and infrastructure requirements. Overall, prioritization reflects sensitivity, usability, and scalability in clinical diagnostics.

Diagnostic Reagents for Infectious Diseases Market- Geographical Insights

North America dominates the diagnostic reagents for infectious diseases market, accounting for the largest revenue share, as robust healthcare infrastructure, significant R&D investment, and high adoption of advanced molecular and immunoassay reagents drive demand across clinical and laboratory settings. The United States leads regional growth, supported by government screening programs and strong private sector participation. Europe holds the second-largest share, with countries such as Germany, France, and the UK emphasizing early disease detection and high-quality reagent adoption, bolstered by public-private partnerships that expand testing capacity. The Asia-Pacific region is emerging as the fastest-growing market due to increased healthcare spending, expanded lab infrastructure, and rising infectious disease prevalence, particularly in China, India, and Japan, encouraging local reagent use and production. Strategic developments include bioMerieux's acquisition of Day Zero Diagnostics in June 2025 to expand reagent portfolios and an October 2025 partnership between Sysmex and QIAGEN for reagent supply and distribution in Japan.

Diagnostic Reagents for Infectious Diseases Market- Country Insights

At the country level, the United States commands a leading position in the diagnostic reagents for infectious diseases market, propelled by advanced healthcare infrastructure, robust molecular testing adoption, and significant public and private investment in early disease detection. Western European countries such as Germany, the United Kingdom, and France follow closely, supported by expanding laboratory networks and strong reagent utilization in both clinical diagnostics and public health screening programs. In the Asia-Pacific region, China and India are rapidly expanding reagent markets due to increased healthcare spending, rising infectious disease prevalence, and initiatives to localize reagent supply chains to reduce dependence on imports, enhancing regional accessibility and reducing costs.

Strategic developments include bioMerieux's acquisition of Day Zero Diagnostics in June 2025 to broaden its infectious disease reagent portfolio and NGS capabilities, and Sysmex's collaboration with QIAGEN in October 2025 to distribute infectious disease reagents and diagnostic products in Japan.

Diagnostic Reagents for Infectious Diseases Market- Competitive Landscape:

The competitive landscape of the diagnostic reagents for infectious diseases market is moderately consolidated, with established players such as bioMerieux SA, QIAGEN, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, and Sysmex Corporation leading through extensive reagent portfolios, global distribution networks, and ongoing innovation in molecular and immunoassay technologies. Continuous investment in R&D, reagent sensitivity, and automation capabilities differentiates market leaders while fostering competition. Mergers and acquisitions are shaping market dynamics; for example, bioMerieux's acquisition of Day Zero Diagnostics in June 2025 expanded its infectious disease reagent offerings and next-generation sequencing workflows. Strategic collaborations also strengthen competitive positioning, such as the Sysmex partnership with QIAGEN in October 2025 for exclusive distribution of infectious disease reagents and diagnostic products in Japan. Smaller firms focus on niche reagent solutions to capture specialized segments, balancing the innovation ecosystem.

Recent Developments:

In January 2024, QIAGEN launched two new QIAstat-Dx syndromic test panels in India-the Gastrointestinal Panel 2 and the Meningitis/Encephalitis Panel-joining the existing Respiratory SARS-CoV-2 Panel to enable rapid, accurate, multiplex infectious disease diagnosis using real-time PCR and single-use cartridges.

In July 2025, Microbix Biosystems launched its QUANTDx(TM) characterized reference materials, a new product line of accurately quantified and fully traceable reference materials covering more than 80 panels for infectious disease assay development and validation, aimed at improving diagnostic assay performance and regulatory readiness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Danaher Corporation
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic
  • Merck KGaA
  • Ortho Clinical Diagnostics
  • QIAGEN
  • QuidelOrtho
  • Randox Laboratories
  • Roche Diagnostics
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Others

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostic Reagents
  • Immunoassay Reagents
  • Clinical Chemistry Reagents
  • Hematology Reagents

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • PCR & RT-PCR
  • ELISA
  • Immunofluorescence
  • Next-Generation Sequencing

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Viral Infections
  • Bacterial Infections
  • Fungal Infections
  • Parasitic Infections

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Disease Diagnosis
  • Blood Screening
  • Epidemiological Surveillance

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Research Institutes

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Diagnostic Reagents for Infectious Diseases Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Diagnostic Reagents for Infectious Diseases Market Snippet by Product Type
    • 2.1.2. Diagnostic Reagents for Infectious Diseases Market Snippet by Technology
    • 2.1.3. Diagnostic Reagents for Infectious Diseases Market Snippet by Disease Type
    • 2.1.4. Diagnostic Reagents for Infectious Diseases Market Snippet by Application
    • 2.1.5. Diagnostic Reagents for Infectious Diseases Market Snippet by End-User
    • 2.1.6. Diagnostic Reagents for Infectious Diseases Market Snippet by Country
    • 2.1.7. Diagnostic Reagents for Infectious Diseases Market Snippet by Region
  • 2.2. Competitive Insights

3. Diagnostic Reagents for Infectious Diseases Key Market Trends

  • 3.1. Diagnostic Reagents for Infectious Diseases Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Diagnostic Reagents for Infectious Diseases Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Diagnostic Reagents for Infectious Diseases Market Opportunities
  • 3.4. Diagnostic Reagents for Infectious Diseases Market Future Trends

4. Diagnostic Reagents for Infectious Diseases Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Diagnostic Reagents for Infectious Diseases Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Diagnostic Reagents for Infectious Diseases Market Landscape

  • 6.1. Diagnostic Reagents for Infectious Diseases Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Diagnostic Reagents for Infectious Diseases Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Molecular Diagnostic Reagents
    • 7.1.3. Immunoassay Reagents
    • 7.1.4. Clinical Chemistry Reagents
    • 7.1.5. Hematology Reagents

8. Diagnostic Reagents for Infectious Diseases Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. PCR & RT-PCR
    • 8.1.3. ELISA
    • 8.1.4. Immunofluorescence
    • 8.1.5. Next-Generation Sequencing

9. Diagnostic Reagents for Infectious Diseases Market - By Disease Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 9.1.2. Viral Infections
    • 9.1.3. Bacterial Infections
    • 9.1.4. Fungal Infections
    • 9.1.5. Parasitic Infections

10. Diagnostic Reagents for Infectious Diseases Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Disease Diagnosis
    • 10.1.3. Blood Screening
    • 10.1.4. Epidemiological Surveillance

11. Diagnostic Reagents for Infectious Diseases Market - By End-User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Diagnostic Laboratories
    • 11.1.4. Blood Banks
    • 11.1.5. Research Institutes

12. Diagnostic Reagents for Infectious Diseases Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Diagnostic Reagents for Infectious Diseases Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. Agilent Technologies
    • 13.2.3. Beckman Coulter
    • 13.2.4. Becton, Dickinson and Company
    • 13.2.5. Bio-Rad Laboratories
    • 13.2.6. Danaher Corporation
    • 13.2.7. DiaSorin
    • 13.2.8. Fujirebio
    • 13.2.9. Grifols
    • 13.2.10. Hologic
    • 13.2.11. Merck KGaA
    • 13.2.12. Ortho Clinical Diagnostics
    • 13.2.13. QIAGEN
    • 13.2.14. QuidelOrtho
    • 13.2.15. Randox Laboratories
    • 13.2.16. Roche Diagnostics
    • 13.2.17. Sekisui Diagnostics
    • 13.2.18. Siemens Healthineers
    • 13.2.19. Sysmex Corporation
    • 13.2.20. Thermo Fisher Scientific
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us